Member Info for AquaeSulis01

Coca cola will come under further pressure to address falling sales but clearly until the US Partner has finalised the structure of sweetbiotix following scale-up then nothing will happen, after that then healthy fibres are an obvious candidate to replace aspartame

Https://www.who.int/news/item/14-07-2023-aspartame-hazard-and-risk-assessment-results-released

Gummies with Slimbiome seem to be popular in the USA as well in the Top 5 and easily the best summary of the 5 gummies listed I would say.

#4. DietWorks Appetite Control -Best Health Supplement For Losing Weight

Brand Overview

At last, a solution to manage your appetite and curb those pesky cravings. DietWorks Appetite Control Prebiotic Gummies are a delicious way to help with weight loss and appetite suppression. Appetite Control Prebiotic Gummies are developed to help you reduce calorie consumption, enhance weight control, and battle unhealthy snacking and overeating impulses, thanks to the patented ingredient SlimBiome.

DietWorks Appetite Control Prebiotic Gummies may support optimal metabolic function by increasing metabolism and balancing digestive tract health. These delicious gummies are produced with natural fruit and make you feel fuller for longer, resulting in less food consumption and a healthy immune system. Appetite Control Prebiotic Gummies are an excellent supplement to any diet because they are non-stimulant.

These tasty raspberry-flavored candies can be had at any time of day and contain 2 grams of dietary fiber.

Features

• SlimBiome

SlimBiome is revolutionizing the way weight reduction is tackled by providing a healthy, hunger-free weight management method based on sound scientific concepts.

SlimBiome is an award-winning multifunctional component that increases satiety, burns fat to promote healthy metabolism, and keeps blood sugar levels in check to prevent overeating. It has been demonstrated to suppress hunger pangs and decrease calorie intake by up to 20%.

SlimBiome takes the guesswork out of weight management by combining cutting-edge microbiome modulation technology with a potent blend of natural substances discovered and developed by top experts in metabolism and nourishment. It has been shown to help people lose weight faster and more sustainably by substituting self-denial with shrinkflation — feeling filled for longer to limit food intake.

Customer Experience

There are numerous customer reviews from people who have tried the product and were pleased with the outcomes. They report that these gummies have helped them cut down on snacking, demonstrating that it is quite effective at suppressing hunger. Their experiences demonstrate that this product aids in weight loss in a healthy way.

Several customers have seen how the results are obvious in a short amount of time and how the product performs well when used consistently. Customers reported a considerable rise in energy levels as well as a major shift in their metabolic rate in addition to fat loss.

https://www.mensjournal.com/entertainment/weight-loss-gummies

Thanks for posting mol. Interesting comment when talking about the popularity of different products giving the example of gummies in China which sell as fast as they can manufacture them. Roll on H1 Results.

Very interesting article including a quote by Unilever Senior R&D Manager, Michael Hoptroff, that explains the excitement felt by Croda regarding skinbiotix, under the heading Prebiotics and Age-Related Skin Concerns

"In the future we could move to different types of prebiotics to feed different microbes (Good news for Opti's Microbiome Modulators) and over time, we could move to postbiotics and probiotics Hoptroff predicted. It is a fast moving sector.

For the time being, however, cosmetic products that deliver probiotics, or live good bacteria face a number of development hurdles. The sheer number of them and the fact that each one performs a different function in a different context, mean that mapping is essential but still some way from realisation. BEYOND that, innovators need to overcome challenges around the delivery system and ensuring that the right number of the right bacteria remain live in a product throughout the shelf-life." . Well, using a lysate has solved the problem in the case of skinbiotix meaning the future has been brought into the here and now I would say

https://www.cosmeticsdesign-europe.com/Article/2022/07/05/Unilever-talks-skin-microbiome-innovation-investment-and-opportunities-in-beauty

"

Https://www.bbc.co.uk/news/health-66119059 Europe's drugs regulator has told BBC News it is conducting a review of some weight-loss jabs after being alerted to a possible link to thoughts of suicide and self-harm among users.

Member state Iceland notified the European Medicines Agency after seeing three cases.

The safety assessment will look at Wegovy, Saxenda and similar drugs, such as Ozempic, that help curb appetite.

Product leaflets already list suicidal thoughts as a possible side effect.

Suicidal behaviour is not currently listed for these prescription drugs.

Celebrity weight loss jab to be sold by chemists

GPs to offer Wegovy on NHS

Are weight loss jabs the answer to tackling obesity?

Laura as well as being a Spanish National is also proficient in Italian which will prove useful for the respective Axis websites in Spain and Italy and dealing with Customer Services

Late reported transaction just shown

07-Jul-23 16:09:47 12.00 1,000,000 Unknown* 12.00 12.25 120.00k

I have just tried a "luxury" twist for my morning slimexpert Golden Syrup porridge (having got the idea when a top hotel mentioned they served porridge with whisky soaked raisins) and it is absolutely delicious. I used sultanas soaked in two fingers of single malt whisky for 2 hrs which has the added bonus of giving the single malt a slightly sweet taste enhancing its flavour, and which I enjoyed the night before, before adding the sultanas to my slimexpert porridge, milk and microwaving for 2 minutes before mixing in a dash of cinnamon.

For those new shareholders, why not call in to your local H&B and buy some of the product to try. it is a healthy breakfast low in salt and slimbiome really does work in terms of satisfying your appetite

Limitations of Simply Wall Street neatly summarised by Motley Fool

https://www.earnmorelivefreely.com/simply-wall-street-review/

My focus will be on the timely delivery of the milestones leading to the Commencement of Construction in the Dry Season, whether we get a RNS for each highlighted step or bundled together in two or three news releases is irrelevant as progress can be closely tracked and will lead to a significant upgrade in the share price when the end point is reached.

Milestones:

Q3

-Trigger Syndicate Board & Committee Approvals

- Proceed to Further Community preparations and sign Final Definitive Documents

- Obtain independent confirmation of compliance with International Banking Stds

*Upgraded Security Systems in position

* Community prep for resettlement & compensation

- Satisfy any admin conditions re insurance & Govt Tenure Certificates

Q4

- Trigger funds drawdowns, start equity release

- Commence Construction in Dry Season

Unless SOH was looking forward to drinking iced tea and coffee at Xmas with sweetbiotix then safe to say can be used in both hot and cold beverages.

Click you are talking about the company already receiving more in annual pre launch royalty payments than skin made from last year's revenue and enough cash to last without generating a single penny of revenue for 12 months

For those chartists amongst you, gap closed at 6.75p, 50 day moving average of 8.75p broken and end of month target 13p. https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-monday-3rd-july-2023/

TheInvest, before the hotstockrocket article, which I have only just read, came out yesterday, I posted here compelling reasons for investing in Opti, none of which included sweetbiotix which would be a cherry on top. If you don't believe the stock is very good value at today's market cap perhaps you would care to read my post and explain what you think I have wrong.

Apeirogon, you are probably best advised to watch the last Investor Meets presentation to get the full facts about sweetbiotix. In essence Material Transfer Agreements with Coca Cola , Tate and Lyle, Kelloggs and 8 other named companies have been in place for a number of years (all companies named on one of the slides), however, the best that can be hoped for is a soft launch using Opti's own products in the near future. Summary from the investor meets "sweetbiotix

- US Partner produced optimised scaled-up version in liquid form Dec 2022 and has now produced it freeze dried May 2023. Taste is fine but novel structure being scrutinised and finalised to ensure it can be properly protected by patents whilst not being too novel to prolong regulatory approval (data feedback expected to be released next couple of months). Soft launch 2023 using Optibiotix own products (such as wellbiome) to trial it with full launch in 2024.

- Firminech have already scaled up from a lab yield of 5% to achieve a yield of 50%, a 70% yield is the target for launch readiness"

The more I review the 2022 figures and the reasons for them and their composition against the circa 300% forecast increase for 2023, the more I realise how low the bar has been set and that SOH will appear like a returning hero this time next year. Besides the likely write back of around £400k bad debt provision, the India Apollo launch 1u8th Sep 2022 netted £61k in just 3 months from several pharmacies and we are told that momentum has increased with sales in April double that in March and further strong growth in May with the aim for Gofigure products to be in 1000 stores by end 2023 including H&B in India, so £400k revenue from that Country alone not unreasonable. US partners for both weight management and Sports Nutrition to be ordering H2 2023 and H1 sales of Diet works Appetite Control Gummies are strong. Compare this with zero US sales 2022 where the £100k is attributable to the annual six digit Sweetbiotix milestone payment. China launch via Tmall has also taken place in 2023 with first orders placed and of course Nahdi in Saudia Arabia launched Jan 2023. Finally, Optipharm marketing has increased and they and H&B are drawing down stock of slimbiome, whilst the e-commerce side of the business is 1200% up. So does anyone believe £1.75M revenue won't be achieved 2023 and if so why? Enough to make me think even elrico might start purchasing Opti again at today's sp before the herd cotton on.

I guess it depends on whether SOH sees it as an ongoing problem with the unnamed Customer or a once off. For instance if the Customer happened to be H&B then may be seen as a historic issue likely to improve going forward. https://www.thegrocer.co.uk/high-street/holland-and-barrett-apologises-over-late-payments-as-owner-concludes-700m-debt-deal/673854.article

True loads, but if you examine the accounts a bit more deply, £458k was the element down to debtors (balance stock write down) and of that £458 figure the following statement applies "31 December 2022 one material debt is overdue, however management have negotiated revised terms and expect to resolve the outstanding amount within 2023.

Having taken account of the nature of the relationship with the customer and the pattern of repayments since the receivable was raised, the Directors expect the amount to be recovered in full, however a credit loss provision of £60,000 has been created to reflect the impact of wider economic uncertainties over the projected collection period.

The Board consider a default to have occurred when a receivable passes 60 days beyond agreed credit terms, at which point regard is had to the specific characteristics of the debtor in assessing exposure to material credit risk and therefore the requirement to create a loss provision. " So all the bad news appears to have been loaded into the 2022 FY which really does give SOH the best possible chance of producing bumper 2023 figures in his first full year back in charge as CEO.

Too many stale bulls here and not enough fresh blood. Apart from the bad debt provision the results were exactly as predicted and the market cap for a company with zero debt, enough cash to last until 2nd qtr 2024 without having to generate a single pound in revenue now that cost reductions are saving over £40k per month have been implemented, not to mention the PBX and Skin assets, makes this company a steal at current sp. 2022 revenue of £475k did not include a single order from the two biggest customers who are once again drawing down slimbiome stock from suppliers having got through their overhang, and with the addition partners Nahdi and Apollo on-board for 2023, every reason to believe the pessimistic £1.75m revenue forecast. Throw in the expected Croda Nov 2023 additional skinbiotix trial announcement revaluing the Skin asset and a soft launch for any of the sweetbiotix products and things start to get very interesting. So as "dogs" go this is a real pedigree when compared to similarly valued cash strapped and asset less companies with nothing like the near term potential here. Agree that Directors putting their hands in their pockets would be welcome, and I suspect would lead to a rapid re-rate in the sp as I do not believe the MM's have that many shares on their hands

Bel they say old age does not come alone so entirely forgivable that you forgot the 23rd Dec RNS Provion update where stock write down action has already been taken. So the good news is that any recent sales increases as a result of promotions may actually lead to a reversal of that write down action